CD29

SKU: P29PU-01MG Categorías: ,

145,69 € excl.VAT – 544,81 € excl.VAT

This antibody reacts with the CD29-antigen, an integrin β1. CD29 complexes with one of nine integrin α subunits to form the very late antigen (VLA) subfamily of adhesion molecules. CD29 is expressed broadly on lymphocytes, monocytes and granulocytes.

Información adicional

Conjugated

, , ,

Size

, ,

Regulatory Status

Clone

Gene ID

Format

Species Reactivity

Isotype

Tested Applications

Clonality

UniProt

Mw

Population

B- Cell, Dendrititic Cell, Endothelial Cell, Epithelial Cell, Granulocyte, Macrophage/Monocyte, NK Cell, Platelet, Stem Cell/Precursor, T-Cell
Almacenamiento Store in the dark at 2-8°C.
Otros nombres

Platelet GPIIa, VLA-beta chain, beta-1 integrin chain, Fibronectin receptor subunit beta, VLA-4 subunit beta.
Buffer

The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3).
Immunogen

Human integrin beta 1.
Concentración

Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml.

Uso recomendado

CD29, clone VJ1/14, is a mAb intended for identification/enumerate human peripheral blood leukocytes suppressor/cytotoxic by FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.

Recursos

Technical Data Sheet (TDS) – (English)

Safety Sheet (MSDS) – (English)

Safety Sheet (Purified) (MSDS) – (English)

Referencias

Product descriptionReferenceTitleAuthorsJournalYear
Product descriptionReferenceTitleAuthorsJournalYear